|
UBR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.98460170309068E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.58160176464162E-11 |
| Normal-vs-Stage2 |
3.782200E-04 |
| Normal-vs-Stage3 |
3.42699999489327E-08 |
| Normal-vs-Stage4 |
1.32699999999542E-06 |
| Stage1-vs-Stage2 |
5.419600E-01 |
| Stage1-vs-Stage3 |
8.148400E-01 |
| Stage1-vs-Stage4 |
4.530600E-01 |
| Stage2-vs-Stage3 |
4.223000E-01 |
| Stage2-vs-Stage4 |
2.545400E-01 |
| Stage3-vs-Stage4 |
4.944800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.04820041535447E-10 |
| Normal-vs-AfricanAmerican |
8.9782004053518E-10 |
| Normal-vs-Asian |
8.760000E-02 |
| Caucasian-vs-AfricanAmerican |
7.052200E-01 |
| Caucasian-vs-Asian |
9.565400E-01 |
| AfricanAmerican-vs-Asian |
8.426600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.36624045410372E-12 |
| Normal-vs-Female |
1.417950E-03 |
| Male-vs-Female |
2.122700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.839500E-04 |
| Normal-vs-Extreme_Weight |
8.14126543957627E-13 |
| Normal-vs-Obese |
5.31070000198142E-08 |
| Normal-vs-Extreme_Obese |
3.56470000000275E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.078000E-01 |
| Normal_Weight-vs-Obese |
9.223000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.771000E-01 |
| Extreme_Weight-vs-Obese |
6.810000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.025800E-01 |
| Obese-vs-Extreme_Obese |
5.841600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.60295999999116E-05 |
| Normal-vs-Age(41-60Yrs) |
9.73749999522155E-08 |
| Normal-vs-Age(61-80Yrs) |
5.03563857279232E-12 |
| Normal-vs-Age(81-100Yrs) |
4.49439999661294E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.788200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.584600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.740240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.400400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.934400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.801200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.73360223346231E-11 |
| Normal-VS-Type2 PRCC |
9.45549971653747E-10 |
| Normal-VS-KIRP CIMP |
7.96350000000778E-05 |
| Normal-VS-Unclassified PRCC |
8.411400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.069800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.214000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.412610E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.577400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.806370E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.860400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.38631378283117E-12 |
| Normal-vs-N1 |
6.70159999716091E-08 |
| Normal-vs-N2 |
6.564600E-04 |
| N0-vs-N1 |
6.397000E-01 |
| N0-vs-N2 |
8.400200E-01 |
| N1-vs-N2 |
7.037600E-01 |
|
|
